Chylomicron processing in familial dysbetalipoproteinemia and familial combined hyperlipidemia studied with vitamin A and E as markers: A new physiological concept

Atherosclerosis

Volumn 149, Issue 1, 2000, Pages 169-180

  Demacker, Pierre N M ^a   Hectors, Magda P C ^a   Stalenhoef, Anton F H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apolipoprotein B 48; Familial combined hyperlipidemia; Familial dysbetalipoproteinemia; Lipid transfer or diffusion; Lipoproteins; Postprandial phase; Vitamin A; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; BIOCHEMICAL MARKER; CHOLESTEROL; CHYLOMICRON; RETINOL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION; FAMILIAL HYPERLIPEMIA; FAT INTAKE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; LIPID TRANSPORT; LIPOLYSIS; LIPOPHILICITY; LIPOPROTEIN BLOOD LEVEL; POSTPRANDIAL STATE; PRIORITY JOURNAL; THERMODYNAMICS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT, ACTIVE; CHYLOMICRONS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; VITAMIN A; VITAMIN E;

EID: 0034001764     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00326-3     Document Type: Article

References (45)

1. Mahley R.W., Rall R.C. Jr Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. Scriver C.R., Beadet A.L., Sly W.S., Valle D. The metabolic basis of inherited disease. vol. II:1995;1953-1980 McGraw-Hill, New York.
2. Kane J.P., Chen G.C., Hamilton R.L., Hardman D.A., Malloy M.J., Havel R.J. Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia. Arteriosclerosis. 3:1983;47-56.
3. Demacker P.N.M., Bredie S.J.H., Vogelaar J.M., Hectors M.P.C., van Heijst P., Stuyt P.M.J. et al. VLDL accumulation in familial dysbetalipoproteinemia is associated with increased exchange or diffusion of chylomicron lipids to apo B-100 containing triglyceride-rich lipoproteins. Atherosclerosis. 138:1998;301-312.
4. Kayden H.J., Traber M.G. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J. Lipid Res. 34:1993;343-358.
5. Traber M.G., Sokol R.J., Burton G.W., Ingold K.U., Papas A.M., Huffaker J.E. et al. Impaired ability of patients with familial isolated vitamin E deficiency to incorporate α-tocopherol into lipoproteins secreted by the lever. J. Clin. Invest. 85:1990;397-407.
6. Goodman D.S. Vitamin A and retinoids in health and disease. New Engl. J. Med. 310:1984;1023-1031.
7. Kayden H.J., Traber M.G. Transport of vitamin E in human lipoproteins. Mino M., Nakamura H., Diplock A.T., Kayden H.J. Vitamin E. Its usefulness in health and in curing diseases. 85:1993;28 Japan Scientific Societies Press, Tokyo.
8. Wilson D.E., Chan I.F., Ball I. Plasma lipoprotein retinoids after vitamin A feeding in normal man: minimal appearance of retinyl esters among low-density lipoproteins. Metabolism. 32:1983;514-517.
9. Zilversmit D.B., Morton R.E., Hughes L.B., Haeflein Thompson K. Exchange of retinyl and cholesteryl esters between lipoproteins of rabbit plasma. Biochem. Biophys. Acta. 712:1982;88-93.
10. Krasinski S.D., Cohn J.S., Schaefer J.S., Russell R.M. Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects: evidence for delayed plasma clearance of intestinal lipoproteins. J. Clin. Invest. 85:1990;883-892.
11. Cohn J.S., Johnson E.J., Millar J.S., Cohn D.S., Milne R.V., Marcel Y.L. et al. Contribution of apo B-48 and apo B-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J. Lipid Res. 34:1993;2033-2040.
12. Demacker P.N.M., Vos-Janssen H.E., van't Laar A., Jansen A.P. A descriptive study of the different electrophoretic patterns on agarose of human serum very low density lipoproteins. Clin. Chem. 24:1978;1419-1444.
13. Hidiroglou N., McDowell L.R., Batra T.R., Papas A.M. Tissue alpha-tocopherol concentrations following supplementation with various forms of vitamin E in sheep. Reprod. Nutr. Dev. 34:1994;273-278.
14. Kuchinskiene Z., Carlson L.A. Composition, concentration and size of low density lipoproteins and of subfractions of very low density lipoproteins from serum of normal men and women. J. Lipid Res. 23:1982;762-769.
15. Havel R.J., Eder H.A., Bragdon J.H. The distribution and clinical composition of ultracentrifugally separated lipoproteins in human serum. J. Lipid Res. 24:1955;1345-1355.
16. Demacker P.N.M., Reijnen I.G.M., Katan M.B., Stuyt P.M.J., Stalenhoef A.F.H. Increased removal of remnants of triglyceride-rich lipoproteins on a diet rich in polyunsaturated fatty acids. Eur. J. Clin. Invest. 21:1991;197-203.
17. Karpe F., Hamsten A. Determination of apolipoprotein B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J. Lipid Res. 35:1994;1311-1317.
18. Bergeron N., Kotite L., Havel R.J. Simultaneous quantification of apolipoproteins B-100, B-48 and E separated by SDS-PAGE. Methods Enzymol. 263:1996;82-94.
19. Schneeman B.O., Kotite L., Todd K.M., Havel R.J. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B48 and B100 to a fat-containing meal in normolipidemic humans. Proc. Natl. Acad. Sci. USA. 90:1993;2063-2073.
20. Björkegren J., Karpe F., Milne R.W., Hamsten A. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low-density lipoproteins isolated from fasting and postprandial plasma. J. Lipid Res. 39:1998;1412-1420.
21. Brenninkmeijer B.J., Stuyt P.M.J., Demacker P.N.M., Stalenhoef A.F.H. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype. J. Lipid Res. 28:1987;361-370.
22. de Graaf J., Hak-Lemmers H.L.M., Hectors M.P.C., Demacker P.N.M., Hendriks J.C.M., Stalenhoef A.F.H. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arteriosclerosis. 11:1991;298-306.
23. Korn E.P. Clearing factor, a heparin activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil. J. Biol. Chem. 215:1955;15-35.
24. Olivecrona T., Bengtsson G. Lipoprotein lipase: the model enzyme. Borgstrom B., Brockman H.L. Lipases. 1984;205-261 Elsevier, Amsterdam.
25. Karpe F., Hultin M. Endogenous triglyceride-rich lipoproteins accumulation in rat plasma when competing with a chylomicron-like triglyceride emulsion for common lipolytic pathway. J. Lipid Res. 26:1995;1557-1566.
26. Brenninkmeijer B.J., Stuyt P.M.J., Demacker P.N.M., Stalenhoef A.F.H., van't Laar A. Catabolism of chylomicron remnants in normolipidic subjects in relationship to the apoprotein E phenotype. J. Lipid Res. 28:1987;361-370.
27. La Rosa J.C., Levy R.I., Herbert P., Lux S.E., Fredrickson D.S. A specific apoprotein activator for lipoprotein lipase. Biochem. Biophys. Res. Commun. 41:1970;57-62.
28. Demacker P.N.M., van Heijst P.J., Stalenhoef A.F.H. A study of the chylomicron metabolism in WHHL rabbits after fat loading. Discrepancy between results based on measurement of apoprotein B-48 or retinyl palmitate. Biochem. J. 285:1992;641-646.
29. Karpe F., Olivercrona T., Hamsten A., Hultin M. Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants. J. Lipid Res. 38:1997;949-961.
30. Cohn J.S., McNamara J.R., Cohn S.D., Ordovas J.M., Schaefer R.J. Plasma apolipoprotein changes in the triglyceride rich lipoprotein fraction of human subjects fed a fat-rich meal. J. Lipid Res. 29:1988;925-936.
31. Parker T.S., McNamara D.J., Brown C.D., Kolb R., Ahrens E.H. Jr, Alberts A.W. et al. Plasma mevalonate as a measure of cholesterol synthesis in man. J. Clin. Invest. 74:1984;795-804.
32. Kempen H.J., Glatz J.F., Gevers-Leuven J.A., van der Voort H.A., Katan M.B. Serum lathosterol concentration is an indicator of whole body cholesterol synthesis in humans. J. Lipid Res. 24:1988;1149-1155.
33. Bjornson L.K., Gniewkowski G., Kayden K.J. A comparison of the exchange of α-tocopherol and of free cholesterol between rat plasma lipoproteins and erythrocytes. J. Lipid Res. 16:1957;39-53.
34. Stalenhoef A.F.H., Malloy M.J., Kane J.P., Havel R.J. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia. J. Clin. Invest. 78:1986;722-728.
35. Karpe F., Bell M., Bjorkegren J., Hamsten A. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoprotein B-48 and B-100. Arterioscler. Thromb. Vasc. Biol. 15:1995;199-207.
36. Salemans L.M.J.L., Nagengast F.M., Tangerman A., van Schaik A., Hopman W.P.M., de Haan A.F.J. et al. Effect of aging on postprandial conjugated and unconjugated serum bile acid levels in healthy subjects. Eur. J. Clin. Invest. 23:1993;192-198.
37. Gould R., Jones R.J., LeRoy G., Wissler R.W., Taylor C.B. Absorbability of β-sitosterol in humans. Metabolism. 18:1969;652-662.
38. Netea M.G., Demacker P.N.M., Kullberg B.J., Boerman O.C., Verschueren I., Stalenhoef A.F.H. et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J. Clin. Invest. 97:1996;1366-1372.
39. De Bont N., Netea M.G., Demacker P.N.M., Verschueren I., Kullberg B.J., van Dijk K.W. et al. Apolipoprotein E knock-out mice are highly susceptible for Klebsiella pneumonia infection. J. Lipid Res. 40:1999;680-686.
40. Kita T., Goldstein J.L., Brown M.S., Watanabe Y., Hornick C.A., Havel R.J. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low-density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 79:1982;362-363.
41. Chait A., Albers J.J., Brunzell J.D. Very low density lipoprotein overproduction in genetical forms of hypertriglyceridemia. Eur. J. Clin. Invest. 10:1980;17-22.
42. Janus E.D., Nicoll A.M., Turner P.R., Magill P., Lewis P. Kinetic bases of the primary hyperlipidemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur. J. Clin. Invest. 10:1980;161-172.
43. Zannis V.I., Just J.L., Breslow J.L. Human apolipoprotein E isoprotein subclasses are genetically determined. Am. J. Hum. Genet. 33:1981;11-24.
44. Demacker P.N.M. Diets and postprandial lipoproteins. Curr. Opin. Lipidol. 6:1995;43-47.
45. Zilversmit D.B. Atherosclerosis: a postprandial phenomenon. Circulation. 60:1979;473-485.